Updates
Here you’ll find the latest headlines from our project. Stay up to date on our latest news items.
Working for Healthcare Professionals – Update WP4
Pneumonia: the Silent Killer?
VITAL poster at World Congress on Public Health 2020
Successful VITAL General Assembly 2020
First Results from Focus Group Study – Update WP4
Research on Heterogeneity of Infectious Diseases’ Problem in Ageing Adults – Update WP3
Start of the First Research – Update WP1
VITAL Infographic Work Package 4
‘VITAL, Boulot, Dodo’ a Blog by Baudouin Standaert
Restart the Clinical Vaccination Study – Update WP2
The Impact of the COVID-19 Pandemic on the VITAL Project
VITAL is vital! A Blog by Debbie van Baarle
Preventing Infectious Diseases for Healthy Ageing: The VITAL Public-Private Partnership Project
Characteristics of Effective Educational Interventions Targeting Healthcare Workers to Improve Advising about Vaccinations for Adults of 50 Years and Older
Short- and Long-term Impact of Vaccination against Cytomegalovirus: a Modeling Study
Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Exploratory Analasys of the Economically Justifiable Price of an RSV Vaccine for the Elderly in the Netherland and United Kingdom
Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)
VITAL Presentation at World Congress on Public Health 2019
Successful VITAL General Assembly 2019
VITAL’s First Kickoff Meeting
European Project VITAL Kicks Off
Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council’s advice
Contact
You can contact us by using the contact form here.
The VITAL project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806776. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.